α-Glucosidase, butyrylcholinesterase and acetylcholinesterase inhibitory activities of phenolic compounds from Carthamus tinctorius L. flowers: In silico and in vitro studies

Jawaher A.M. Alotaibi,Alaa Sirwi,Ali M. El-Halawany,Ahmed Esmat,Gamal A. Mohamed,Sabrin R.M. Ibrahim,Abdulrahim A. Alzain,Taher F. Halawa,Martin Safo,Hossam M. Abdallah
DOI: https://doi.org/10.1016/j.jsps.2024.102106
IF: 4.562
2024-05-19
Saudi Pharmaceutical Journal
Abstract:Chemical investigation of Carthamus tinctorius L. flowers resulted in isolation of seven metabolites that were identified as; p -Hydroxybenzoic acid ( 1 ), trans hydroxy cinnamic acid ( 2 ), kaempferol-6-C-glucoside ( 3 ), astragalin ( 4 ), cartormin ( 5 ), kaempferol-3- O -rutinoside ( 6 ), and kaempferol–3- O -sophoroside ( 7 ). Virtual screening of the isolated compounds against human intestinal α-glucosidase, acetylcholinesterase, and butyrylcholinesterase was carried out. Additionally, the antioxidant activity of the bioactive compounds was assessed. Compounds 1 and 5 exhibited moderate binding affinities to acetylcholinesterase (binding energy −5.33 and −4.18 kcal/mol, respectively), compared to donepezil. Compounds 1 to 7 demonstrated weak affinity to butyrylcholinesterase. Compound 4 displayed very strong binding affinity to human intestinal α-glucosidase, better than Acarbose (reference compound), meanwhile compound 2 exhibited lower affinity. Molecular dynamic studies revealed that compound 4 formed a stable complex with the binding site throughout a 100 ns simulation period. The in-vitro results were consistent with the virtual experimental results, as compounds 1 and 5 showed mild inhibitory effects on acetylcholinesterase (IC 50 s 150.6–168.7 μM). Compound 4 exhibited significant α-glucosidase inhibition with an IC 50 of 93.71 μM. The bioactive compounds also demonstrated notable antioxidant activity in ABTS [2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)], ORAC (oxygen radical-absorbance capacity), and metal chelation assays, suggesting their potential in improving dementia in Alzheimer's disease (AD) and mitigating hyperglycemia.
pharmacology & pharmacy
What problem does this paper attempt to address?